...
首页> 外文期刊>Veterinary Immunology and Immunopathology >Screening scFv antibodies against infectious bursal disease virus by co-expression of antigen and antibody in the bacteria display system
【24h】

Screening scFv antibodies against infectious bursal disease virus by co-expression of antigen and antibody in the bacteria display system

机译:通过在细菌展示系统中共表达抗原和抗体来筛选针对传染性法氏囊病病毒的scFv抗体

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously reported an antigen and antibody co-expression (AAC) technology to demonstrate the interaction between a known antigen and antibody. To validate the co-expression system for screening antibody libraries, a single chain fragment variable(scFv)antibody library was constructed from chickens immunized with the VP2 protein of infectious bursal disease virus (IBDV). The genes of both VP2 and scFv antibodies were inserted into the pBFD-Ab-Ag vector. The co-expression library was subjected to three rounds of screening by flow cytometry (FCM) using a polyclonal antibody against VP2 through a bacteria display system. We achieved enrichment of scFv specific for IBDV. 110 individual clones were initially selected and sequenced. Twenty clones were selected based on fluorescence intensity by FCM. The scFv antibodies were expressed by pET-27b in E. coli and purified. The specificity and affinity of the selected scFv antibodies were confirmed by western blotting assay and ELISA analysis. What's more, the neutralizing capacity was measured with IBDV-B87(100 TCID50) in vitro. Four scFvs (clone 8(1), Y8, L10 and L7) showed significant neutralizing capacity. Two of the four scFvs (clone 8(1) and Y8) demonstrated a higher neutralizing activity to IBDV-B87 and the titers were 16,384 and 8,192, respectively. The two scFvs had higher neutralizing capacity than those obtained in previous studies. We demonstrated that the AAC technology could be applied to screen antibody libraries without baiting antigen to make antibody screening process easier and obtain scFvs with higher neutralizing capacity. (C) 2016 Elsevier B.V. All rights reserved.
机译:我们先前已经报道了抗原和抗体共表达(AAC)技术,以证明已知抗原和抗体之间的相互作用。为了验证用于筛选抗体文库的共表达系统,从用鸡传染性法氏囊病病毒(IBDV)VP2蛋白免疫的鸡中构建了单链片段可变(scFv)抗体库。 VP2和scFv抗体的基因都插入到pBFD-Ab-Ag载体中。使用抗VP2的多克隆抗体通过细菌展示系统,通过流式细胞术(FCM)对共表达文库进行三轮筛选。我们实现了针对IBDV的scFv的富集。最初选择了110个单独的克隆并进行了测序。基于FCM的荧光强度选择了20个克隆。 scFv抗体通过pET-27b在大肠杆菌中表达并纯化。所选的scFv抗体的特异性和亲和力通过蛋白质印迹分析和ELISA分析得到证实。此外,中和能力是用IBDV-B87(100 TCID50)在体外测量的。四个scFv(克隆8(1),Y8,L10和L7)显示出明显的中和能力。四个scFv中的两个(克隆8(1)和Y8)表现出对IBDV-B87更高的中和活性,效价分别为16,384和8,192。与以前的研究相比,这两种scFv具有更高的中和能力。我们证明了AAC技术可以应用于筛选抗体文库而无需引诱抗原,从而使抗体筛选过程更容易,并获得具有更高中和能力的scFv。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号